Literature DB >> 1551410

Somatically mutated IgG anti-DNA antibody clonally related to germ-line encoded IgM anti-DNA antibody.

S Taki1, S Hirose, K Kinoshita, H Nishimura, T Shimamura, J Hamuro, T Shirai.   

Abstract

Among 15 anti-DNA antibody-producing hybridomas derived from a single NZB X NZW F1 mouse, an IgM and an IgG were shown to use the same VH gene of the Q52 family. Using a combination of two primers both consisting of a mixture of oligonucleotides (one complementary to the 5' end of VH segment and one to the 3' end of VH segment of Q52 family) we determined the sequences of several members of germ-line VH genes in the Q52 family derived from NZB and NZW strains. Comparison of the sequences with those of cloned VH cDNA obtained from the hybridomas revealed that the VH sequence of the IgM anti-DNA antibody was identical to that of a cloned NZW germ-line VH gene, except for the priming sites. In contrast, the VH sequence of the IgG counterpart contained somatically mutated nucleotides. Because the IgG anti-DNA antibody showed a higher DNA binding activity than did the IgM antibody, we conclude that these changes in nucleotide sequences were induced and selected through an antigen-driven mechanism as is the case in a normal immune response. It is tempting to speculate that the germ-line encoded, low-affinity IgM autoantibody undergoes somatic mutations and isotype switching, resulting in generation of pathogenic, high-affinity autoantibodies in autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1551410     DOI: 10.1002/eji.1830220417

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  8 in total

1.  Precursor B cells for autoantibody production in genomically Fas-intact autoimmune disease are not subject to Fas-mediated immune elimination.

Authors:  S Hirose; K Yan; M Abe; Y Jiang; Y Hamano; H Tsurui; T Shirai
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

Review 2.  Significance of MHC class II haplotypes and IgG Fc receptors in SLE.

Authors:  Sachiko Hirose; Yi Jiang; Hiroyuki Nishimura; Toshikazu Shirai
Journal:  Springer Semin Immunopathol       Date:  2006-09-14

3.  Therapeutic effect of leflunomide on the development of experimental lupus nephritis in mice.

Authors:  Chunyan He; Xuehong Lu; Zhaowei Yan; Man Wu; Shujun Liu; Yongli Yu; Ping Luo
Journal:  Rheumatol Int       Date:  2010-12-03       Impact factor: 2.631

4.  Immunoregulatory characteristics of the in vitro anti-ssDNA response.

Authors:  C C Anderson; A Panoskaltsis; N R Sinclair
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

5.  V gene analysis of anti-cardiolipin antibodies from (NZW x BXSB) F1 mice.

Authors:  Y Kita; T Sumida; I Iwamoto; S Yoshida; T Koike
Journal:  Immunology       Date:  1994-07       Impact factor: 7.397

6.  Expansion of a B-lymphocyte clone producing IgM auto-antibodies encoded by a somatically mutated VHI gene in the spleen of an autoimmune patient.

Authors:  S Jahn; B Niemann; T Winkler; J R Kalden; R von Baehr
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

7.  Both IgM and IgG anti-DNA antibodies are the products of clonally selective B cell stimulation in (NZB x NZW)F1 mice.

Authors:  D M Tillman; N T Jou; R J Hill; T N Marion
Journal:  J Exp Med       Date:  1992-09-01       Impact factor: 14.307

8.  Increased levels of anti-dsDNA antibodies in immune complexes before treatment with belimumab associate with clinical response in patients with systemic lupus erythematosus.

Authors:  Azita Sohrabian; Ioannis Parodis; Nellie Carlströmer-Berthén; Martina Frodlund; Andreas Jönsen; Agneta Zickert; Christopher Sjöwall; Anders A Bengtsson; Iva Gunnarsson; Johan Rönnelid
Journal:  Arthritis Res Ther       Date:  2019-11-29       Impact factor: 5.156

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.